Inventor · Cambridge, MA, US

Stuart Milstein

89Patents
12h-index
80Co-inventors
83Inventor score

Filing activity: Oct 20, 2009 → Oct 8, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US8168775B2 Compositions and methods for inhibiting expression of transthyretin Chemistry; Metallurgy 34 Active
US9322018B2 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 27 Active
US8741866B2 Compositions and methods for inhibiting expression of transthyretin Chemistry; Metallurgy 24 Active
US10233448B2 Modified double-stranded RNA agents Chemistry; Metallurgy 21 Active
US9771591B2 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 16 Active
US10612027B2 Modified double-stranded RNA agents Chemistry; Metallurgy 15 Active
US9234196B2 Compositions and methods for inhibiting expression of transthyretin Chemistry; Metallurgy 13 Active
US8273869B2 Lipid formulated dsRNA targeting the PCSK9 gene Chemistry; Metallurgy 13 Active
US10337010B2 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 12 Active
US9127274B2 Serpinc1 iRNA compositions and methods of use thereof Chemistry; Metallurgy 12 Active
US10557139B2 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 12 Active
US10550390B2 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 12 Active
US8598139B2 Lipid formulated dsRNA targeting the PCSK9 gene Chemistry; Metallurgy 12 Active
US11504391B1 Modified RNA agents with reduced off-target effect Chemistry; Metallurgy 12 Active
US10238749B2 Angiotensinogen (AGT) iRNA compositions and methods of use thereof Chemistry; Metallurgy 8 Active
US10995336B2 Serpina1 iRNA compositions and methods of use thereof Chemistry; Metallurgy 6 Active
US11130953B2 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 5 Active
US8293718B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 5 Active
US10246713B2 TMPRSS6 iRNA compositions and methods of use thereof Chemistry; Metallurgy 5 Active
US10513703B2 Hepatitis B virus (HBV) iRNA compositions and methods of use thereof Chemistry; Metallurgy 5 Active
US8623838B2 Organic compositions to treat HSF1-related diseases Emerging Cross-Sectional Technologies 5 Active
US9376680B2 Serpinc1 iRNA compositions and methods of use thereof Chemistry; Metallurgy 5 Active
US8481509B2 Organic compositions to treat HSF1-related diseases Chemistry; Metallurgy 5 Active
US10407679B2 Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Chemistry; Metallurgy 4 Active
US10240152B2 Compositions and methods for inhibiting expression of transthyretin Chemistry; Metallurgy 4 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.